Cite

HARVARD Citation

    Bennett, A. et al. (2020). A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease. Crohn's & colitis 360. 2 (1), p. . [Online]. 
  
Back to record